Nasonex (a nasal steroid used in the treatment of allergies and nasal congestion) had been launched several years previously with little focus or promotion.
A Pharmaceutical Company with 5 new major products of Global importance undergoing health technology appraisal with little corporate support leading to initially negative NICE advice
A pharmaceutical Company affiliate in the UK was failing with 30% staff turnover, failure to meet financial targets and key functions absent or vacant
A pharmaceutical company high potential executive appointed to their first Country Managing Director during a global recession
A young pharmaceutical company in transition with a relatively inexperienced team and little corporate support.